Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

Insulin Icodec

Aliases
Insulin 287, insulin icodec, Insulin icodec

9 clinical trials

3 indications

Indication
Diabetes Mellitus
Indication
Type 2
Indication
Type 1
Clinical trial
Pharmacodynamic Properties of Insulin Icodec During Exercise and Prolonged Fasting in Participants With Type 2 Diabetes
Status: Recruiting, Estimated PCD: 2024-11-04
Clinical trial
A Trial Investigating the Pharmacokinetics and Pharmacodynamics of NNC0148-0287 C (Insulin 287) at Steady State Conditions in Subjects With Type 1 Diabetes
Status: Completed, Estimated PCD: 2020-06-26
Clinical trial
A Study to Evaluate Flash Glucose Monitoring Based Titration of Once-weekly Insulin Icodec in Insulin-naïve Participants With Type 2 Diabetes
Status: Completed, Estimated PCD: 2024-02-28
Clinical trial
A Study Investigating the Pharmacokinetic Properties of a Single Dose of IcoSema Compared With Insulin Icodec and Semaglutide Given Separately in Chinese Participants With Type 2 Diabetes
Status: Completed, Estimated PCD: 2023-04-25
Clinical trial
A Single Arm Study Investigating the Glycaemic Control and Safety of Adding Semaglutide to Insulin Icodec in Participants With Type 2 Diabetes Qualifying for Treatment Intensification
Status: Recruiting, Estimated PCD: 2024-09-03
Clinical trial
Efficacy and Safety of Once Weekly Insulin Icodec Compared to Once Daily Insulin Degludec 100 Units/mL, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes. A 26-week, Randomised, Multicentre, Open-label, Active-controlled, Parallel Group, Two Armed, Treat-to-target Trial Investigating the Effect on Glycaemic Control and Safety of Treatment With Once Weekly Insulin Icodec Compared to Once Daily Insulin Degludec, Both in Combination With Insulin Aspart in Adults With Type 1 Diabetes, With a 26-week Extension Investigating Long Term Safety
Status: Completed, Estimated PCD: 2022-04-28
Clinical trial
A 26-week Trial Comparing the Effect and Safety of Once Weekly Insulin Icodec and Once Daily Insulin Degludec, Both With or Without Non-insulin Anti-diabetic Drugs, in Subjects With Type 2 Diabetes Treated With Basal Insulin
Status: Completed, Estimated PCD: 2022-01-27
Clinical trial
A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Insulin Icodec in Subjects With Type 2 Diabetes
Status: Completed, Estimated PCD: 2022-04-22
Clinical trial
A Trial Investigating the Hypoglycaemic Response to Overdosing of NNC0148-0287 C (Insulin 287) in Subjects With Type 2 Diabetes
Status: Completed, Estimated PCD: 2021-09-27